Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Pharmaceutical Combination Comprising A Selective S1 P1 Receptor Agonist
Abstract: The present invention relates to a pharmaceutical combination comprising a first active ingredient which is (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)- benz[Z]ylidene]-2-([Z]- propylimino)-3-o-tolyl-thiazolidin-4-one or a pharmaceutically acceptable salt thereof and a second active ingredient which is selected from the group consisting of methyl fumarate, (N,Ndiethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, and 2- (2,5- dioxopyrrolidin-1-yl)ethyl methyl (2E)but-2-ene-1,4-dioate, or a pharmaceutically acceptable salt thereof.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
04 November 2022
Publication Number
48/2022
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
patent@depenning.com
Parent Application
Applicants
ACTELION PHARMACEUTICALS LTD.
Gewerbestrasse 16, CH-4123 Allschwil, Switzerland
Inventors
1. CLOZEL, Martine
c/o Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123 Allschwil, Switzerland
2. PIALI, Luca
Oberalpstrasse 13, CH-4054 Basel, Switzerland
Specification
Description:Please refer to the attachment. , Claims:Please refer to the attachment.
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202248063164-AbandonedLetter.pdf | 2023-12-26 |
| 1 | 202248063164-STATEMENT OF UNDERTAKING (FORM 3) [04-11-2022(online)].pdf | 2022-11-04 |
| 2 | 202248063164-REQUEST FOR EXAMINATION (FORM-18) [04-11-2022(online)].pdf | 2022-11-04 |
| 2 | 202248063164-FER.pdf | 2022-12-23 |
| 3 | 202248063164-PROOF OF RIGHT [04-11-2022(online)].pdf | 2022-11-04 |
| 3 | 202248063164-FORM 3 [14-11-2022(online)].pdf | 2022-11-14 |
| 4 | 202248063164-COMPLETE SPECIFICATION [04-11-2022(online)].pdf | 2022-11-04 |
| 4 | 202248063164-PRIORITY DOCUMENTS [04-11-2022(online)].pdf | 2022-11-04 |
| 5 | 202248063164-POWER OF AUTHORITY [04-11-2022(online)].pdf | 2022-11-04 |
| 5 | 202248063164-DECLARATION OF INVENTORSHIP (FORM 5) [04-11-2022(online)].pdf | 2022-11-04 |
| 6 | 202248063164-FORM 18 [04-11-2022(online)].pdf | 2022-11-04 |
| 6 | 202248063164-DRAWINGS [04-11-2022(online)].pdf | 2022-11-04 |
| 7 | 202248063164-FORM 1 [04-11-2022(online)].pdf | 2022-11-04 |
| 7 | 202248063164-FIGURE OF ABSTRACT [04-11-2022(online)].pdf | 2022-11-04 |
| 8 | 202248063164-FORM 1 [04-11-2022(online)].pdf | 2022-11-04 |
| 8 | 202248063164-FIGURE OF ABSTRACT [04-11-2022(online)].pdf | 2022-11-04 |
| 9 | 202248063164-FORM 18 [04-11-2022(online)].pdf | 2022-11-04 |
| 9 | 202248063164-DRAWINGS [04-11-2022(online)].pdf | 2022-11-04 |
| 10 | 202248063164-DECLARATION OF INVENTORSHIP (FORM 5) [04-11-2022(online)].pdf | 2022-11-04 |
| 10 | 202248063164-POWER OF AUTHORITY [04-11-2022(online)].pdf | 2022-11-04 |
| 11 | 202248063164-COMPLETE SPECIFICATION [04-11-2022(online)].pdf | 2022-11-04 |
| 11 | 202248063164-PRIORITY DOCUMENTS [04-11-2022(online)].pdf | 2022-11-04 |
| 12 | 202248063164-PROOF OF RIGHT [04-11-2022(online)].pdf | 2022-11-04 |
| 12 | 202248063164-FORM 3 [14-11-2022(online)].pdf | 2022-11-14 |
| 13 | 202248063164-REQUEST FOR EXAMINATION (FORM-18) [04-11-2022(online)].pdf | 2022-11-04 |
| 13 | 202248063164-FER.pdf | 2022-12-23 |
| 14 | 202248063164-STATEMENT OF UNDERTAKING (FORM 3) [04-11-2022(online)].pdf | 2022-11-04 |
| 14 | 202248063164-AbandonedLetter.pdf | 2023-12-26 |
Search Strategy
| 1 | SearchHistoryE_19-12-2022.pdf |